Trypsin Inhibitors
Showing 1 - 25 of 4,188
Non-Coeliac Wheat Sensitivity (NCWS), Irritable Bowel Syndrome Trial (Amylase trypsin inhibitors, Placebo)
Not yet recruiting
- Non-Coeliac Wheat Sensitivity (NCWS)
- Irritable Bowel Syndrome
- Amylase trypsin inhibitors
- Placebo
- (no location specified)
Jul 19, 2022
Irritable Bowel Syndrome Trial in Hamilton (Purified gluten, Non-purified gluten (containing ATIs), Nocebo)
Unknown status
- Irritable Bowel Syndrome
- Purified gluten
- +2 more
-
Hamilton, Ontario, CanadaMcMaster University Medical Centre
Sep 25, 2020
Eosinophilic Esophagitis Trial (Alpha-proteinase inhibitor)
Not yet recruiting
- Eosinophilic Esophagitis
- Alpha-proteinase inhibitor
- (no location specified)
Aug 2, 2022
Non-celiac Gluten Sensitivity, Wheat Hypersensitivity Trial in Stuttgart, Lübeck (Wheat bread)
Recruiting
- Non-celiac Gluten Sensitivity
- Wheat Hypersensitivity
- Wheat bread
-
Stuttgart, Baden-Württemberg, Germany
- +1 more
Nov 28, 2023
Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))
Recruiting
- Alpha1-Antitrypsin Deficiency
- Alpha-1 15%
- Liquid Alpha1-Proteinase Inhibitor (Human)
-
Gainesville, Florida
- +5 more
Jan 13, 2023
Non-celiac Gluten Sensitivity, Wheat Intolerance Trial in Stuttgart (bread)
Completed
- Non-celiac Gluten Sensitivity
- Wheat Intolerance
- bread
-
Stuttgart, GermanyUniversity of Hohenheim
Oct 26, 2021
KIR Genes and Non-Celiac Wheat Sensitivity
Not yet recruiting
- Non-celiac Wheat Sensitivity
- KIR genotyping
-
Sciacca, Agrigento, Italy
- +3 more
Jul 19, 2022
Spondylitis, Ankylosing Trial in Grenoble (Etanercept ® 50 mg)
Completed
- Spondylitis, Ankylosing
- Etanercept ® 50 mg
-
Grenoble, FranceUniversity Hospital Grenoble
Jun 13, 2022
Sepsis, Septic Shock Trial in Beijing (ulinastatin, Placebo)
Recruiting
- Sepsis
- Septic Shock
- ulinastatin
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 14, 2021
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
Recruiting
- Acute Pancreatitis
- Neutrophil/Lymphocyte Ratio in acute pancreatitis
-
Assiut, EgyptAhmed Mohammed Abu-Elfatth
May 5, 2023
GVHD, Bone Marrow Transplant Failure, Alpha 1-Antitrypsin Trial in Israel
Active, not recruiting
- GVHD
- +2 more
-
Jerusalem, Center, Israel
- +3 more
Mar 9, 2021
Biological Characteristics of Mesothelioma Patients
Completed
- Malignant Mesothelioma
-
Rozzano, Milano, Italy
- +1 more
Sep 8, 2022
Effect of Drug Trial in Cairo (post operative analgesics)
Completed
- Effect of Drug
- post operative analgesics
-
Cairo, EgyptAhmed Abdel Rahman Hashem
Jul 27, 2022
Osteoarthritis, Tendinitis, Sports Injury Trial in Encino (Umbilical Allograft)
Not yet recruiting
- Osteoarthritis
- +7 more
- Umbilical Allograft
-
Encino, CaliforniaAdvanced Stem Cell Institute
Sep 10, 2021
Alpha 1-Antitrypsin Deficiency, Genetic Disease Trial in United States
Recruiting
- Alpha 1-Antitrypsin Deficiency
- Genetic Disease
-
Birmingham, Alabama
- +9 more
Jul 4, 2022
How Secreted-embryo-derived Trypsin Initiates, Maintains and
Active, not recruiting
- Infertility
- +2 more
- Exposure to culture media
-
Abu Dhabi, United Arab EmiratesART Fertility Clinics LLC
Feb 1, 2023
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy
Recruiting
- Advanced Breast Cancer
- The combination of Dalpiciclib with physician-selected endocrine therapy
- Chemotherapy selected by the physician
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Musculoskeletal Health in Breast Cancer During Aromatase
Recruiting
- Musculoskeletal Health
- No intervention
-
Shanghai, Shanghai, ChinaSchool of Nursing, Fudan University
Jun 16, 2023
SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac
Recruiting
- Coronary Artery Disease
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
-
Shah Alam, Selangor, MalaysiaInstitute for Clinical Research, National Institutes of Health,
Nov 9, 2023
Bile Acids in Acute Insulin Resistance
Recruiting
- PI3K Gene Mutation
- +4 more
- Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022
ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced
Completed
- NSCLC
- Immune checkpoint inhibitors plus angiogenesis inhibitors
- Immune checkpoint inhibitors without angiogenesis inhibitors
-
Suzhou, Jiangsu, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023
Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)
Recruiting
- Breast Feeding
- +3 more
- Venipuncture
-
Leuven, Vlaams-Brabant, BelgiumUniversitaire Ziekenhuizen Leuven
Oct 12, 2023